This strategic acquisition substantially expands InnoSer’s preclinical neurology portfolio, adding i...
![](https://resources.innoserlaboratories.com/hubfs/Imported_Blog_Media/InnoSer-x-Sylics-.png)
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
This strategic acquisition substantially expands InnoSer’s preclinical neurology portfolio, adding i...
Getting closer to understanding cancer through the adoption of technological advancements is crucial...
We strive to stay at the forefront of biotechnological developments and to constantly incorporate in...
Animal testing has played a critical role in the development of drugs, enabling us to ultimately obt...
We are constantly looking for opportunities to exchange and develop ideas, as they are the foundatio...
We are eager to join the Dutch life sciences conference – a great opportunity for high-quality netwo...
We look forward to connecting and learning from other life-science companies at events such as the l...
Connecting with bright minds and staying at the forefront of technological developments keeps us inf...
Many methods to measure pharmacodynamic endpoints are currently available, for instance, enzyme-link...
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.